Tumor cells often express or secrete soluble mediators such as IL-10, TGF-β, and prostaglandin E2 that dampen the anti-tumor response or polarize immune populations toward anti-inflammatory phenotypes, yielding T regulatory cells, M2 macrophages, and myeloid-derived suppressor cells [64, 65]. The gene discussed is IL10; the disease is neoplasm.